Getting patients started on KESIMPTA® (ofatumumab)
Screen
Perform bloodwork to screen patients of HBV and test their Ig levels.1 Hint: HBV and Ig testing can be added to your patient’s regular blood panels
Show
Demonstrate KESIMPTA administration using the Sensoready® Demo Pen. Demo pens and videos are provided by Novartis (including supplemental one-on-one virtual training for patients)1
Get a Demo Pen Station Today
Start
Start today with samples.*
Submit 1-page Start Form and see additional helpful resources to help support you and your staff in starting patients
*Sample program is only available to patients who are determined to be appropriate candidates for treatment with KESIMPTA and is intended to give patients a chance to see if KESIMPTA may be right for them. Contact your Sales Representative to learn more.
BRITTANY Q.
Artist, MS Advocate
Switched to KESIMPTA in 2022
“The way the pen is designed puts the needs of people like me first.”
See what Brittany loves about the pen
Real patient taking KESIMPTA who was compensated for time.
Individual results may vary.
Once you prescribe, we aim to deliver
†Coverage data are provided by Managed Markets Insight & Technology and data on file, current as of May 2024.2
‡81% of patients with commercial insurance have first-line coverage.3
See what support we offer your office and patients
Helpful Resources
Download Brochure with Patient Cases and Clinical Data
Download the KESIMPTA Start Form
Download the KESIMPTA Start Form (Spanish)
Download Authorization and Appeals Kit
Download Patient Authorization Form
Download Patient Authorization Form (Spanish)
See educational content from your peers about KESIMPTA
Visit the KESIMPTA Digital Education Lab